DD153691A5 - Verfahren zur herstellung von hexahydro-trans-4a,9b-1(h)pyridoindol-derivaten - Google Patents

Verfahren zur herstellung von hexahydro-trans-4a,9b-1(h)pyridoindol-derivaten Download PDF

Info

Publication number
DD153691A5
DD153691A5 DD80222915A DD22291580A DD153691A5 DD 153691 A5 DD153691 A5 DD 153691A5 DD 80222915 A DD80222915 A DD 80222915A DD 22291580 A DD22291580 A DD 22291580A DD 153691 A5 DD153691 A5 DD 153691A5
Authority
DD
German Democratic Republic
Prior art keywords
meaning
formula
derivative
enantiomeric
racemic
Prior art date
Application number
DD80222915A
Other languages
German (de)
English (en)
Inventor
Willard Welch
Charles A Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD153691A5 publication Critical patent/DD153691A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DD80222915A 1979-07-30 1980-07-28 Verfahren zur herstellung von hexahydro-trans-4a,9b-1(h)pyridoindol-derivaten DD153691A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/061,573 US4252811A (en) 1979-07-30 1979-07-30 Hexahydro-trans-pyridoindole neuroleptic agents

Publications (1)

Publication Number Publication Date
DD153691A5 true DD153691A5 (de) 1982-01-27

Family

ID=22036658

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80222915A DD153691A5 (de) 1979-07-30 1980-07-28 Verfahren zur herstellung von hexahydro-trans-4a,9b-1(h)pyridoindol-derivaten

Country Status (33)

Country Link
US (1) US4252811A (es)
JP (1) JPS5626891A (es)
KR (1) KR840000914B1 (es)
AR (1) AR226314A1 (es)
AT (1) AT375659B (es)
AU (1) AU513948B2 (es)
BE (1) BE884530A (es)
CA (1) CA1133483A (es)
CH (1) CH644379A5 (es)
CS (1) CS221974B2 (es)
DD (1) DD153691A5 (es)
DE (1) DE3028555A1 (es)
DK (1) DK148140C (es)
EG (1) EG14903A (es)
ES (1) ES493818A0 (es)
FI (1) FI68828C (es)
FR (1) FR2463140A1 (es)
GB (1) GB2055372B (es)
GR (1) GR69664B (es)
IE (1) IE50035B1 (es)
IL (1) IL60695A (es)
IT (1) IT1194815B (es)
LU (1) LU82662A1 (es)
NL (1) NL180216C (es)
NO (1) NO153729C (es)
NZ (1) NZ194467A (es)
PH (1) PH22657A (es)
PL (1) PL133456B1 (es)
PT (1) PT71623B (es)
SE (1) SE438505B (es)
SU (1) SU1172450A3 (es)
YU (1) YU42223B (es)
ZA (1) ZA804604B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337250A (en) * 1979-07-30 1982-06-29 Pfizer Inc. Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents
US4748247A (en) * 1986-10-21 1988-05-31 American Home Products Corporation 2-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]alkyl]alkyl]pyrido- and pyrazino-indole-1,3-dione derivatives as histamine H1 antagonists
US5102889B1 (en) * 1990-09-27 1993-05-11 2-(4-piperidinyl)-1h-pyrido(4,3-b)indol-1-ones and related compounds
US5229517A (en) * 1990-09-27 1993-07-20 Hoechst-Roussel Pharmaceuticals Incorporated 2-(4-Piperindinyl)-1H-pyrido[4,3-B]indol-1-ones and related compounds
JPH05101365A (ja) * 1991-03-22 1993-04-23 Tdk Corp 垂直磁気記録媒体およびその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687961A (en) * 1971-05-03 1972-08-29 Abbott Lab 8-fluoro-2-{8 3-(4-fluorophenylanilinopropyl{9 -gamma-carboline
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (es) * 1974-03-20 1975-10-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
SE7702301L (sv) * 1976-04-08 1977-10-09 Endo Lab Trans-hexahydro-pyrido-indoler

Also Published As

Publication number Publication date
DE3028555A1 (de) 1981-02-12
CA1133483A (en) 1982-10-12
KR830003480A (ko) 1983-06-20
KR840000914B1 (ko) 1984-06-28
AU513948B2 (en) 1981-01-15
PT71623A (en) 1980-08-01
IE801576L (en) 1981-01-30
SE8005453L (sv) 1981-01-31
AT375659B (de) 1984-08-27
NL180216C (nl) 1987-01-16
BE884530A (fr) 1981-01-29
SE438505B (sv) 1985-04-22
ATA393280A (de) 1984-01-15
ES8105732A1 (es) 1981-05-16
NO153729C (no) 1986-05-14
DK260080A (da) 1981-01-31
LU82662A1 (fr) 1981-03-24
GR69664B (es) 1982-07-07
DK148140C (da) 1985-09-16
CS221974B2 (en) 1983-04-29
FR2463140B1 (es) 1983-07-22
PH22657A (en) 1988-10-28
NL8004332A (nl) 1981-02-03
IL60695A0 (en) 1980-09-16
IE50035B1 (en) 1986-02-05
JPS6357433B2 (es) 1988-11-11
FI68828C (fi) 1985-11-11
PL133456B1 (en) 1985-06-29
PL225940A1 (es) 1982-11-08
FI802371A (fi) 1981-01-31
IT8023785A0 (it) 1980-07-29
YU42223B (en) 1988-06-30
EG14903A (en) 1985-12-31
FR2463140A1 (fr) 1981-02-20
JPS5626891A (en) 1981-03-16
GB2055372B (en) 1983-05-05
US4252811A (en) 1981-02-24
YU191780A (en) 1983-12-31
FI68828B (fi) 1985-07-31
NO802274L (no) 1981-02-02
NZ194467A (en) 1984-05-31
IL60695A (en) 1983-11-30
ZA804604B (en) 1981-07-29
NO153729B (no) 1986-02-03
CH644379A5 (fr) 1984-07-31
AR226314A1 (es) 1982-06-30
PT71623B (en) 1982-06-09
DK148140B (da) 1985-03-18
NL180216B (nl) 1986-08-18
IT1194815B (it) 1988-09-28
ES493818A0 (es) 1981-05-16
SU1172450A3 (ru) 1985-08-07
GB2055372A (en) 1981-03-04

Similar Documents

Publication Publication Date Title
DE69103206T2 (de) Neue Derivate des Aminopiperidins, Aminopyrrolidins und des Aminoperhydroazepins, Verfahren zur Herstellung und diese enthaltende Arzneimittel.
EP0569802A1 (de) Arylacetamide
EP0000928A1 (de) Neue Nitroimidazole und diese enthaltende pharmazeutische Präparate sowie deren Herstellung
EP0136658A2 (de) 1-Benzyl-aminoalkyl-pyrrolidinone und ihre Säureadditionssalze, Verfahren zu ihrer Herstellung und Arzneimittel
EP0047923B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
EP0670318A2 (de) Acetamide mit analgetischer und neuroprotektiver Wirkung
DE102005001411A1 (de) Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament
EP0000220B1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE69120899T2 (de) Neue N-Benzoylprolin-Derivate, Verfahren zur Herstellung und diese enthaltende Arzneimittel
EP0483580A2 (de) 1-(2-Arylethyl)-Pyrrolidine
CH665419A5 (de) 1-(hydroxymethyl)-1,6,7,11b-tetrahydro-2h,4h-(1,3)-oxazino- bzw. -thiazino(4,3-a)isochinolinderivate, verfahren zu ihrer herstellung und ein arzneimittelpraeparat.
DE69720021T2 (de) 1,4-disubstituierte piperazine
CH645371A5 (de) Isochromane, isothiochromane, 2-benzoxepine und 2-benzothiepine.
CH675418A5 (es)
DE3850308T2 (de) Tetrahydroisochinolin-2-yl-Derivate als Thromboxan A2-Antagonisten.
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
EP0072960B1 (de) 1,5-Diphenylpyrazolin-3-on-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD153691A5 (de) Verfahren zur herstellung von hexahydro-trans-4a,9b-1(h)pyridoindol-derivaten
DE2556457A1 (de) 2-methoxy-benzamidderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3305495A1 (de) Piperazin- und homopiperazinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
EP0007525A1 (de) 2-(4-Aminopiperidino)-3,4-dihydrochinoline, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
DE1090667B (de) Verfahren zur Herstellung von basischen Phenthiazinderivaten
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten
DE2656227C2 (de) Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE1095836B (de) Verfahren zur Herstellung von in 10-Stellung basisch substituierten Phenthiazinderivaten